{"id":"NCT02465567","sponsor":"Pearl Therapeutics, Inc.","briefTitle":"Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)","officialTitle":"A Randomized, Double-Blind, Multi-Center, Parallel-Group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD (Ethos)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-30","primaryCompletion":"2019-07-26","completion":"2019-07-26","firstPosted":"2015-06-08","resultsPosted":"2021-02-02","lastUpdate":"2021-02-02"},"enrollment":8588,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["COPD"],"interventions":[{"type":"DRUG","name":"BGF MDI 320/14.4/9.6 μg","otherNames":["BGF"]},{"type":"DRUG","name":"GFF MDI 14.4/9.6 μg","otherNames":["GFF"]},{"type":"DRUG","name":"BGF MDI 160/14.4/9.6 μg","otherNames":["BGF"]},{"type":"DRUG","name":"BFF MDI 320/9.6 μg","otherNames":["BFF"]}],"arms":[{"label":"BGF (PT010) MDI 320/14.4/9.6 μg","type":"EXPERIMENTAL"},{"label":"BGF (PT010) MDI 160/14.4/9.6 μg","type":"EXPERIMENTAL"},{"label":"BFF (PT009) MDI 320/9.6 μg","type":"EXPERIMENTAL"},{"label":"GFF (PT003) MDI 14.4/9.6 μg","type":"EXPERIMENTAL"}],"summary":"This is a randomized, double-blind, multi-center, parallel-group study to assess the efficacy and safety of PT010 relative to PT003 and PT009 on COPD exacerbations subjects with moderate to very severe COPD.","primaryOutcome":{"measure":"Adjusted Rate of Moderate or Severe Exacerbations","timeFrame":"52-week treatment period","effectByArm":[{"arm":"BGF MDI 320/14.4/9.6 μg","deltaMin":1.08,"sd":0.04},{"arm":"BGF MDI 160/14.4/9.6 μg","deltaMin":1.07,"sd":0.04},{"arm":"GFF MDI 14.4/9.6 μg","deltaMin":1.42,"sd":0.05},{"arm":"BFF MDI 320/9.6 μg","deltaMin":1.24,"sd":0.04}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG003","p":"0.0027"},{"comp":"OG001 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG003","p":"0.0020"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":741,"countries":["United States","Argentina","Australia","Austria","Belgium","Canada","Chile","China","Czechia","France","Germany","Hungary","Italy","Japan","Mexico","Netherlands","New Zealand","Peru","Poland","Russia","Serbia","South Africa","Spain","Sweden","Taiwan","United Kingdom"]},"refs":{"pmids":["39691156","35815359","35614467","32579807","31605923"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":426,"n":2144},"commonTop":["Nasopharyngitis","Upper respiratory tract infection"]}}